DermTopic: Psoriasis

Filter Your Results

 

News

 

FDA Approves Expanded Use Of Enbrel To Treat Children With C…

The FDA has approved the supplemental Biologics License Application (sBLA) for the expanded use of Amgen's Enbrel (e…

Allergan Completes Vitae Tender Offer

Allergan completed their tender offer to purchase all outstanding shares of Vitae Pharmaceuticals, Inc., a clinical-stag…

Moving Beyond PASI

The Psoriasis Area Severity Index (PASI) was first introduced into our dermatology lexicon in 1978 by Frediksson and Pet…

Jerry Bagel, MD and Elise Nelson, LPN

Biosim Update: Pfizer to Begin Shipping INFLECTRA in Late No…

Pfizer Inc. will begin shipment of INFLECTRA (infliximab-dyyb) for injection, a biosimilar of REMICADE1 (infliximab) to …

DermWireTV: AD Impact, Allofill Comes to Market, GPA Launche…

From sleep disruptions or negative impact on the ability to work to feelings of depression and anxiety, atopic dermatiti…

DermWire.com

Game Change: The New Global Psoriasis Atlas to Accrue Worldw…

Three global health organizations are joining forces to launch the Global Psoriasis Atlas (GPA), the first-ever worldwid…

Stelara Adds New Approval: Crohn's Disease

The FDA has approved STELARA® (ustekinumab) from Janssen Biotech, Inc., for the treatment of moderately to severely …

FDA Approves Humira Biosimilar

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) f…

 
 

Contact Info

For advertising rates and opportunities:
Ali Kinnie
(917) 589-4160
akinnie@bmctoday.com

Rick Ehrlich
Associate Publisher
(609) 922-0337
rehrlich@bmctoday.com

About Practical Dermatology

Practical Dermatology is the monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. With straight-forward, how-to advice from experts in various fields, we strive to enhance quality of care and improve the daily operation of dermatology practices.